← All trials
NCT06936527
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 23, 2025
- Primary completion
- Apr 30, 2028
- Completion date
- Jul 30, 2028
- First posted
- Apr 20, 2025
- Last posted
- Sep 3, 2025
- Enrollment
- 102
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- NovaOnco Therapeutics Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.